Prostate cancer risk and initial treatment decisions in the PLCO cancer screening trial

被引：0
|
作者：
Grubb, Robert L.
Miller, David C.
Church, Timothy R.
Hickey, Thomas
Greenlee, Robert T.
Lzmirlian, Grant
Mabie, Jerome
Riley, Thomas L.
Ragard, Lawrence
Prorok, Philip C.
Berg, Christine D.
Crawford, E. David
Andriole, Gerald L.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60439-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：153 / 153
页数：1
相关论文
共 50 条
  • [1] Serum metabolomic profiling of prostate cancer risk in the PLCO Cancer Screening Trial
    Mondul, Alison M.
    Koutros, Stella
    Weinstein, Stephanie J.
    Berndt, Sonja I.
    Albanes, Demetrius
    CANCER RESEARCH, 2016, 76
  • [2] LETHAL PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL
    Shoag, Jonathan
    Mittal, Sameer
    Halpem, Joshua
    Scherr, Douglas
    Hu, Jim
    Barbieri, Christopher
    JOURNAL OF UROLOGY, 2016, 195 (04): : E390 - E390
  • [3] Lethal Prostate Cancer in the PLCO Cancer Screening Trial
    Shoag, Jonathan
    Mittal, Sameer
    Halpern, Joshua A.
    Scherr, Douglas
    Hu, Jim C.
    Barbieri, Christopher E.
    EUROPEAN UROLOGY, 2016, 70 (01) : 2 - 5
  • [4] Prostate cancer screening in the prostate, lung, colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screening round of a randomized trial
    Andriole, GL
    Levin, DL
    Crawford, ED
    Gelmann, ER
    Pinsky, PF
    Chia, D
    Kramer, BS
    Reding, D
    Church, TR
    Grubb, RL
    Izmirlian, G
    Ragard, LR
    Clapp, JD
    Prorok, PC
    Gohagan, JK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06): : 433 - 438
  • [5] Re: Lethal Prostate Cancer in the PLCO Cancer Screening Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 196 (06): : 1677 - 1677
  • [6] Red meat intake and prostate cancer risk in the PLCO Cancer Screening Trial.
    Cross, AJ
    Peters, U
    Andriole, GL
    Reding, D
    Hayes, RB
    Sinha, R
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1890S - 1890S
  • [7] FAMILY HISTORY AND INCREASED RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL
    Bernstein, Adrien
    Golan, Ron
    Shoag, Jonathan
    Dinerman, Brian
    Hu, Jim C.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E897 - E897
  • [8] Vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial
    Hoyt, Margaret
    Reger, Michael
    Marley, Andrew
    Fan, Hao
    Liu, Ziyue
    Zhang, Jianjun
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 109 (02): : 392 - 401
  • [9] Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial
    Buys, SS
    Partridge, E
    Greene, MH
    Prorok, PC
    Reding, D
    Riley, TL
    Hartge, P
    Fagerstrom, RM
    Chia, D
    Izmirlian, G
    Fouad, M
    Ragard, LR
    Johnson, CC
    Gohagan, JK
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (05) : 1630 - 1639
  • [10] PATTERN OF PSA CHANGE DURING SERIAL SCREENING IN THE PLCO CANCER SCREENING TRIAL AFFECTS PROSTATE CANCER RISK
    Grubb, Robert L., III
    Black, Amanda
    Reding, Douglas
    Hickey, Thomas
    Pinsky, Paul F.
    Church, Timothy R.
    Izmirlian, Grant
    Riley, Thomas
    Mabie, Jerome
    Ragard, Lawrence R.
    Berg, Christine D.
    Prorok, Philip C.
    Crawford, E. David
    Andriole, Gerald L., Jr.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 811 - 812
12345